NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery

Loading news article.

NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery | WAPE

NeOnc Technologies Granted Investigational New Drug Status From Abu Dhabi's Department Of Health For NEO100 To Treat Non-Invasive Nose-To-Brain Delivery

Article summary

Related companies

Comments —